D2C7 for Adult Patients With Recurrent Malignant Glioma
NCT02303678
Brain Diseases, Brain Neoplasms
Durham, North Carolina, United States
View Trial DetailsNCT Number: NCT04013828
This qualitative study explores the lived experience of high-grade glioma patients and their close relatives at time of recurrence. With focus on the decision-making about treatment and care..
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Copenhagen University Hospital; Rigshospitalet, Copenhagen, Denmark
High-Grade Glioma is a life-threatening disease that can cause the patient substantial physical, mentally and psychosocially impairment. The life expectancy is short, and a majority of patients experience recurrence of tumour growth. At time of recurrence, the treatment possibilities can include surgery, oncological treatment and/or palliative care.
In this situation the patients and their close relatives need to make a difficult balancing between benefits and trade offs.
Little is known about how the patients and their close relatives experience the recurrence and the decision-making process.
The objective of this study is therefore to explore the perspectives, experiences and needs in patients and their close relatives in relation to the decision-making process at time of recurrence.
Data will be generated through semi-structured interviews. Interviews will be analysed and interpreted using a Ricoeur inspired method of qualitative analysis.
The study is part of a larger PhD-study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Interviews are performed 2-6 weeks after the decision-making
How patients and their close relatives experience the decision-making process
Time frame: Interviews are performed 2-6 weeks after the decision-making
The preferences of patients and relatives for being involved in the decision-making.
Odense University Hospital
Other
Recurrent High-grade Glioma: Experiences of Patients and Their Close Relatives During the Treatment Decision-making Process.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02303678
Brain Diseases, Brain Neoplasms
Durham, North Carolina, United States
View Trial DetailsNCT03213678
Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Non-Hodgkin Lymphoma
Birmingham, Alabama, United States
View Trial DetailsNCT04817254
Astrocytoma, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT03746080
Astrocytoma, Glioblastoma
Palo Alto, California, United States
View Trial Details